[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0

Authors :: Fenton Ingram
Lucia Zanoni
Frode Willoch
David M. Schuster
Tore Bach-Gansmo
Stefano Fanti
Heikki Minn
Cristina Nanni
Ephraim Parent Edward
Bital Savir-Baruch
Eugene Teoh
Trond Velde Bogsrud
Nanni C, Zanoni L, Bach-Gansmo T, Minn H, Willoch F, Bogsrud TV, Edward EP, Savir-Baruch B, Teoh E, Ingram F, Fanti S, Schuster DM.
Source :: Nanni, C, Zanoni, L, Bach-Gansmo, T, Minn, H, Willoch, F, Bogsrud, T V, Edward, E P, Savir-Baruch, B, Teoh, E, Ingram, F, Fanti, S & Schuster, D M 2020, ' [ 18 F]Fluciclovine PET/CT : joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0 ', European journal of nuclear medicine and molecular imaging, vol. 47, no. 3, pp. 579-591 . https://doi.org/10.1007/s00259-019-04614-y
Publication Year :: 2019
Publisher :: Springer Science and Business Media LLC, 2019.
Abstract: The aim of this guideline is to provide standards for the recommendation, performance, interpretation, and reporting of [18F]Fluciclovine PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of [18F]Fluciclovine PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice.

Tools